AK Medical Holdings (HKSE:01789) Days Sales Outstanding : 215.25 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Days Sales Outstanding?

AK Medical Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was HK$574 Mil. AK Medical Holdings's Revenue for the six months ended in Dec. 2023 was HK$487 Mil. Hence, AK Medical Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 215.25.

The historical rank and industry rank for AK Medical Holdings's Days Sales Outstanding or its related term are showing as below:

HKSE:01789' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.71 Med: 80.31 Max: 197.55
Current: 169.84

During the past 10 years, AK Medical Holdings's highest Days Sales Outstanding was 197.55. The lowest was 46.71. And the median was 80.31.

HKSE:01789's Days Sales Outstanding is ranked worse than
91.01% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 64.88 vs HKSE:01789: 169.84

AK Medical Holdings's Days Sales Outstanding increased from Dec. 2022 (154.45) to Dec. 2023 (215.25).

AK Medical Holdings Days Sales Outstanding Historical Data

The historical data trend for AK Medical Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings Days Sales Outstanding Chart

AK Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

81.70

124.39

197.55

154.82

154.87

AK Medical Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial													250.87	137.45	154.45	151.30	215.25

Competitive Comparison of AK Medical Holdings's Days Sales Outstanding

For the Medical Devices subindustry, AK Medical Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AK Medical Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's Days Sales Outstanding falls into.

AK Medical Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

AK Medical Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (521.594	+	493.733)	/	2 )	/	1196.443	*	365
=	507.6635					/	1196.443	*	365
=	154.87

AK Medical Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (654.868	+	493.733)	/	2 )	/	486.924	*	365 / 2
=	574.3005					/	486.924	*	365 / 2
=	215.25

AK Medical Holdings (HKSE:01789) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

AK Medical Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

AK Medical Holdings (HKSE:01789) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200

Website

https://www.ak-medical.net/index.html

AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.

Executives

Li Zhijiang
Trident Trust Company (hk) Limited
Ximalaya Limited
The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Suntop Limited	2101 Beneficial owner
Zhang Chaoyang	2307 Founder of a discretionary trust who can infl
Bamboo Group Management Limited	2201 Interest of corporation controlled by you
Zhang Bin	2202 Interest of your spouse
Rainbow Holdings Limited	2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner
Orbimed Advisors Ii Limited
Orbimed Asia Gp Ii, L.p.
Orbimed Asia Partners Ii, L.p.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines